Navigation Links
ISTA Pharmaceuticals Announces 2010 Financial Guidance
Date:2/9/2010

IRVINE, Calif., Feb. 9 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA) today announced financial guidance for the full year 2010.  The Company expects net revenue will be approximately $147 to $165 million.  In addition, ISTA's management anticipates reporting its first profitable year in 2010, with earnings per share for the full year expected to be at least $0.02, excluding any mark-to-market adjustments relating to warrants.  

"2010 will mark ISTA's transition from a young development company to a financially independent commercial organization," stated Vicente Anido, Jr., Ph.D., President and Chief Executive Officer of ISTA Pharmaceuticals.  "By offering products with differentiated value propositions for both the physician and the patient and building a strong and motivated commercial team, we will have achieved this milestone five years after launching our first product, Istalol, which was closely followed by the launch of our flagship product, Xibrom.  As we look to 2010 and beyond, Bepreve, Xibrom, XiDay, bepotastine nasal spray, and bromfenac for dry eye stand out as our long-term growth drivers, and we are excited about ISTA's future."  

2010 Financial Outlook in Detail

  • We expect our net revenue for 2010 will be approximately $147 to $165 million.  We continue to assume there will not be a generic competitor to Xibrom in 2010.  We expect sales from our Xibrom franchise (including XiDay, assuming U.S. Food and Drug Administration (FDA) approval) to be in the range of $95 to $105 million<
    '/>"/>

SOURCE ISTA Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... 20, 2015  Johnson & Johnson (NYSE: JNJ ... for the investment community beginning at 8:30 a.m. (Eastern ... Regency Hotel in New Brunswick, New Jersey ... Paul Stoffels , M.D., Worldwide Chairman Pharmaceuticals, ... Worldwide Chairman, Pharmaceuticals will host the meeting. Dominic ...
(Date:4/20/2015)... DUBLIN , Apr. 14, 2015 Research and ... addition of the "US Proton Therapy Outlook - ... According to the US Proton Therapy Outlook: Market Opportunities ... will be home to almost 29 such centers ... current figure. Consequently, the market will breach the Billion ...
(Date:4/20/2015)... 2015  Ameritox,s Ingenuity Health, a leading provider of ... research at the National Council of Behavioral Health annual ... that nearly 25 percent of the samples collected from ... the prescribed antipsychotic medication. ... Medication ...
Breaking Medicine Technology:United States Proton Therapy Outlook to 2018 - Market Opportunities for the $1.19 Billion Market Featuring IBA, Hitachi, Mevion Medical Systems & Varian 2United States Proton Therapy Outlook to 2018 - Market Opportunities for the $1.19 Billion Market Featuring IBA, Hitachi, Mevion Medical Systems & Varian 3Ingenuity Health Research Flags Potentially High Rate of Medication Nonadherence Among Those with Serious Mental Illness 2Ingenuity Health Research Flags Potentially High Rate of Medication Nonadherence Among Those with Serious Mental Illness 3
... Dec. 1, 2011 Mylan Inc. (Nasdaq: MYL ) ... Besylate and Atorvastatin Calcium Tablets, 2.5 mg/10 mg, 2.5 mg/20 mg, ... mg, 5 mg/80 mg, 10 mg/10 mg, 10 mg/20 mg, 10 ... Caduet ® Tablets, which are used in the treatment of ...
... 2011  Henry Schein, Inc., (NASDAQ: HSIC ), ... to office-based practitioners, announced today that Stanley Bergman, Chairman ... Paladino, the Company,s Executive Vice President and Chief Financial ... Program on December 6.  The conference is being held ...
Cached Medicine Technology:Henry Schein to Present at the NASDAQ OMX 27th Investor Program 2
(Date:4/20/2015)... Florida Hospital at Connerton Long Term Acute Care ... Medical, during the annual ceremony hosted at the Grand ... Officer, Debi Martoccio, received the Leadership Award for demonstrating ... recipients out of 113 hospitals nationwide. The hospital also ... contributions to the community as well as a separate ...
(Date:4/20/2015)... TROY Healthcare Solutions will be hosting ... software, which provides the ultimate level of security for ... the Anthem Suite Hotel in the Socrates Room, located ... , Beginning at 7 AM, TROY Healthcare Solutions will ... Healthcare Solutions will offer brief 15-20 minute presentations each ...
(Date:4/20/2015)... 2015 “ Verus ” was featured ... which features the latest and coolest technology products available ... reporter for NewsWatch, conducted the review and shared with ... of purposes. , According to CNET, at least a ... 2013. It’s unfortunate that smartphones break so easily, but ...
(Date:4/20/2015)... "It's so hard to put into words ... I really thought I would just be paying for ... I've discovered is this need that other baby loss ... other and walk through this journey together," says Ramsey ... more from these families than I could ever hope ...
(Date:4/20/2015)... Spring Hill, FL (PRWEB) April 20, 2015 ... public health issue in the United States for decades. ... lives, lost productivity, healthcare costs and property damage each ... on its victims, as well as their families and ... Suncoast Rehabilitation Center is dedicated to raising ...
Breaking Medicine News(10 mins):Health News:Florida Hospital at Connerton Long Term Acute Care Earns Awards from Select Medical including the Stu Dinney Humanitarian Award 2Health News:Florida Hospital at Connerton Long Term Acute Care Earns Awards from Select Medical including the Stu Dinney Humanitarian Award 3Health News:TROY Healthcare to Offer Prescription Solutions that Could Save a Health System $100,000 2Health News:TROY Healthcare to Offer Prescription Solutions that Could Save a Health System $100,000 3Health News:Attractive and Durable Phone Cases were Featured on NewsWatch Television 2Health News:3 Years Later, Ramsey Keller Memorial Founder Reflects on Baby Loss, Giving Back by Paying for Infant Funerals in Montana and Receiving More Than She Will Ever Give 2Health News:3 Years Later, Ramsey Keller Memorial Founder Reflects on Baby Loss, Giving Back by Paying for Infant Funerals in Montana and Receiving More Than She Will Ever Give 3Health News:Drunk Driving Repeat Offenders: Suncoast Rehab Center Observes Alcohol Awareness Month by Advocating for Preventive Measures Against DUIs 2Health News:Drunk Driving Repeat Offenders: Suncoast Rehab Center Observes Alcohol Awareness Month by Advocating for Preventive Measures Against DUIs 3Health News:Drunk Driving Repeat Offenders: Suncoast Rehab Center Observes Alcohol Awareness Month by Advocating for Preventive Measures Against DUIs 4
... Data transparency improves patient satisfaction scores, ... to more effectively,measure individual performance and improve ... By incorporating patient,satisfaction benchmarks established through Press ... Press Ganey score by 2 points within ...
... Jan. 25 Super Bowl Sunday,s almost here-and,what better ... healthy,and losing some weight. Right? As more than 90 ... biggest event of the year, we,plan parties predicting the ... With those big-guy pro,s gearing up for Super ...
... --New York, NY-- Researchers in Belgium have significantly advanced ... capacity to generate new insulin-producing beta cells. If the ... progenitor cells may represent an obvious target for therapeutic ... in the Jan. 25 issue of the research journal ...
... To Settle, LOS ANGELES, Jan. 25 An ... made recently,when it came to the table to settle ... was filed Dec. 21, 2007 in Orange,County Superior Court, ... approval by the Multnomah County Circuit Court and,should receive ...
... Va., Jan. 25 - In a speech,earlier this ... the,company was in the initial stages of offering ... executive vice president and CEO,of the National Community ... PBM industry badly needs to be reformed. The ...
... got calls from those who had gotten procedure ... Jan. 25 (HealthDay News) -- Patients who have had ... the screening for colorectal cancer, say University of Pennsylvania ... who received telephone mentoring from a trained "peer coach" ...
Cached Medicine News:Health News:Emory Healthcare Uses SciHealth to Improve Patient Satisfaction 2Health News:Super Bowl and SuperFoods: Play Smart 2Health News:Elusive pancreatic progenitor cells found in mice 2Health News:Elder Care Operator and Plaintiff Attorney Announce Unprecedented Settlement Agreement in Class Action Lawsuit 2Health News:Elder Care Operator and Plaintiff Attorney Announce Unprecedented Settlement Agreement in Class Action Lawsuit 3Health News:NCPA Statement on Wal-Mart's Entry Into the Pharmacy Benefit Market 2Health News:Colonoscopy 'Coaches' Play Lifesaving Role 2
... The Rotanta 460 family ... extraordinary line that meets ... demands. They feature high ... Their state-of-the-art technology and ...
... 15 centrifuge provides all the ... for today's full-service clinical lab ... a speed up to 15,300 ... spin tubes, plates and rotors ...
... Autocrit Ultra has an uniquely ... a facility in which tubes ... in the same carrying tray. ... built-in magnifier, quiet operation, automatic ...
The Spinchron 15 centrifuge provides all the versatility and high capacity needed for today's full-service clinical lab needs. This centrifuge is available in a nonrefrigerated model with a speed up ...
Medicine Products: